Disease Activity and Progression in Multiple Sclerosis: New Evidences and Future Perspectives
- PMID: 36431119
- PMCID: PMC9695838
- DOI: 10.3390/jcm11226643
Disease Activity and Progression in Multiple Sclerosis: New Evidences and Future Perspectives
Abstract
Multiple sclerosis (MS) is a chronic, debilitating, autoimmune-mediated, inflammatory disease of the central nervous system (CNS), in which a combination of inflammation, demyelination and axonal degeneration takes place with extreme highly interpersonal variability [...].
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Mirmosayyeb O., Brand S., Barzegar M., Afshari-Safavi A., Nehzat N., Shaygannejad V., Sadeghi Bahmani D. Clinical Characteristics and Disability Progression of Early and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis. J. Clin. Med. 2020;9:1326. doi: 10.3390/jcm9051326. - DOI - PMC - PubMed
-
- Kapica-Topczewska K., Collin F., Tarasiuk J., Czarnowska A., Chorąży M., Mirończuk A., Kochanowicz J., Kułakowska A. Assessment of Disability Progression Independent of Relapse and Brain MRI Activity in Patients with Multiple Sclerosis in Poland. J. Clin. Med. 2021;10:868. doi: 10.3390/jcm10040868. - DOI - PMC - PubMed
-
- Temmerman J., Van Der Veken F., Engelborghs S., Guldolf K., Nagels G., Smeets D., Allemeersch G.-J., Costers L., D’hooghe M.B., Vanbinst A.-M., et al. Brain Volume Loss Can Occur at the Rate of Normal Aging in Patients with Multiple Sclerosis Who Are Free from Disease Activity. J. Clin. Med. 2022;11:523. doi: 10.3390/jcm11030523. - DOI - PMC - PubMed
-
- Kulczyńska-Przybik A., Dulewicz M., Doroszkiewicz J., Borawska R., Litman-Zawadzka A., Arslan D., Kułakowska A., Kochanowicz J., Mroczko B. Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis. J. Clin. Med. 2022;11:4122. doi: 10.3390/jcm11144122. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
